CDIB Capital
2023 preview: Private debt
Asia-based private debt managers hope to take advantage of renewed LP appetite for the asset class, while enjoying higher returns driven by rising interest rates and widening spreads
China enterprise AR specialist Rokid raises $160m
Rokid, a China-based company specialising in augmented reality (AR) technology applications, has raised USD 160m in Series C funding across two tranches.
CDIB leads round for Taiwan crypto-fiat start-up
CDIB Capital Group has led a $17 million pre-Series A round for Xrex, a Taiwan-based financial technology player that uses blockchain to facilitate cross-border payments by small and medium-sized enterprises (SMEs).
CDIB, Firstred, Huatai buy China cosmetics packaging business
CDIB Capital has teamed up with Firstred Capital and Huatai International Private Equity Fund to acquire 100% of Chinese cosmetics packaging company Yuga Holdings for an undisclosed sum.
Asia credit fundraising: Middle muddle
Various structural tailwinds are driving the development of Asia’s middle-market private credit space. This doesn’t necessarily make it any easier to raise funds for the strategy
Private equity & credit: Seeking synergies
GPs are placing greater emphasis on Asia private debt strategies to capture deals that don’t work as private equity. Much can be achieved by pooling ideas and resources, but collaboration isn’t as straightforward as it seems
Asia fund administration: Odd jobs
COVID-19 is the latest in a growing list of drivers causing private equity firms to outsource various operations. The trend is implacable but inherently flexible
Panacea leads $40m Series C for China's XWPharma
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Asia gyms: Muscling through the mire
Fitness centers have continued to woo investors during COVID-19 despite patchy progress in the reopening of gyms and difficult-to-digitize business models
CDIB adds managing director in China
CDIB Capital has named Stephen Li, previously a managing director at Ping An Trust Private Equity Capital, as a managing director responsible for China.
Taiwan technology: Homeward bound?
Taiwan is encouraging its industrial technology manufacturers to relocate operations from the mainland to the domestic market in response to China-US tensions. This may create openings for PE and VC investors
CDIB completes acquisition of Taiwan's Jintex
CDIB Capital has confirmed completion of its NT$1.9 billion ($61 million) acquisition of Taiwanese chemicals producer Jintex.
Ex-Carlyle executive named head of buyouts at CDIB
CDIB Capital has appointed Alex Ying, who previously spent nearly 20 years with The Carlyle Group, as head of its newly created buyout group.
Deal focus: Jollibee circles as Coffee Bean booms in Asia
The Philippines’ Jollibee Foods is set to buy US cafe chain The Coffee Bean & Tea Leaf to continue a massive Asian expansion effort. Exiting investor CDIB Capital attests to the opportunity set
PE investors exit The Coffee Bean & Tea Leaf to Jollibee
Advent International, CDIB Capital and Mirae Asset Private Equity are set to exit US-based cafe chain The Coffee Bean & Tea Leaf after the Philippines’ Jollibee Foods agreed to pay $350 million for the company.
Deal focus: CDIB finds media consumption proxy
CDIB Capital is backing VHQ China to leverage the growing demand for visual effects in China's domestic movie and TV production industry
CDIB Capital appoints Asia healthcare head
CDIB Capital has named Robert Liu as a managing director and co-head of its regional healthcare practice group in Shanghai.
CDIB invests in China VFX player
CDIB Capital has invested an undisclosed amount in VHQ China, a Taiwan-based provider of post-production and visual effects services focused on China’s film and TV drama industry.
CDIB makes $61m tender offer for Taiwan's Jintex
CDIB Capital, the private equity arm of China Development Financial, has launched a tender offer for Taiwan-based chemical producer Jintex that values the company at NT$1.87 billion ($60.5 million).
Taiwan LPs: Increased exposure
As much as $10 billion could be released for investment in private equity following a hike in alternatives allocations for Taiwanese insurers. However, the major players will still deploy their capital with caution
Alibaba, Line invest Taiwan's KKday
Alibaba Group and Line Corporation have led an extended Series B round of undisclosed size for KKday, a Taiwan-based travel services company backed by a number of venture capital firms.
Deal focus: China baby boom market comes of age
Warburg Pincus has acquired Chinese mother-and-baby company Leyou, providing an exit for CDIB Capital and The Carlyle Group. The deal signals a rapid maturation process in the segment
Warburg Pincus seals secondary buyout of China's Leyou
Warburg Pincus has agreed to acquire a majority stake in Chinese maternity products supplier Leyou. The deal will facilitate exits for The Carlyle Group and CDIB Capital.
CDIB backs Korean cosmetic masks manufacturer
CDIB Capital, the private equity arm of Taiwan’s China Development Financial, has invested an undisclosed sum in Korean cosmetics maker E.CIS Cosmetic (ECIS).